Inflammation and oxidative stress in patients on hemodiafiltration

American Journal of Nephrology

Volumn 28, Issue 6, 2008, Pages 949-957

  Filiopoulos, Vasilis ^a   Hadjiyannakos, Dimitrios ^a   Metaxaki, Polixeni ^a   Sideris, Vasilis ^b   Takouli, Lambrini ^a   Anogiati, Angeliki ^b   Vlassopoulos, Dimosthenis ^a  

^a AMALIA FLEMING GENERAL HOSPITAL   (Greece)

^b Pendeli Pediatric Hospital   (Greece)

Author keywords

End stage renal disease; Hemodiafiltration; Inflammation; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SPECTROPHOTOMETRY;

AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIAFILTRATION; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OXIDATIVE STRESS; RENAL DIALYSIS; SUPEROXIDE DISMUTASE;

EID: 53549092747     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000142724     Document Type: Article

References (44)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305.
2. Rayner HC, Pisoni RL, Bommer J, Canaud B, Hecking E, Locatelli F, Piere L, Bragg-Gresham JL, Feldman HI, Goodkin DA, Gillespie B, Wolfe RA, Held PJ, Port FK: Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004;19:108-120.
3. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C: Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003;18:1272-1280.
4. Pawlak K, Naumnik B, Brzosko S, Pawlak D, Mysilieiec M: Oxidative stress - a link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients. Am J Nephrol 2004;24:154-161.
5. Spittle MA, Hoenich NA, Handelman GJ, Adhikarla R, Homel P, Levin NW: Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis 2001;38:1408-1413.
6. Nguyen-Khoa T, Massy ZA, De Bandt JP, Kebebe M, Salama L, Lambrey G, Witko-Sarsat V, Drüeke TB, Lacour B, Thevenin M: Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 2001;16:335-340.
7. Yamashita AC: Mechanisms of fluid and solute removal in hemodiafiltration. Contrib Nephrol. Basel, Karger, 2007, vol 158, pp 50-56.
8. Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW, Depner T, Klassen P, Port FK: Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 2006;69:2087-2093.
9. Ramirez R, Carracedo J, Merino A, Nogueras S, Alvarez-Lara MA, Rodriguez M, Martin-Malo A, Tetta C, Aljama P: Microinflammation induces endothelial damage in hemodialysis patients: the role of convective transport. Kidney Int 2007;72:108-113.
10. Daugirdas JT: Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn. Adv Ren Replace Ther 1995;2:295-304.
11. Benzie IFF, Strain JJ: The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: The FRAP assay. Anal Biochem 1996;239:70-76.
12. Cesarone MR, Belgaro G, Carratelli M, Cornelli U, De Sanctis MT, Incandela L, Barsotti A, Terranova R, Nicolaides A: A simple test to monitor oxidative stress. Int Angiol 1999; 18:127-130.
13. Hemodialysis Adequacy 2006 Work Group: Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 2006;48(suppl 1):91-97.
14. Mezzano D, Pais EO, Aranda E, Panes O, Downey P, Ortiz M, Taqle R, Gonzalez F, Quiroqa T, Caceres MS, Leighton F, Pereira J: Inflammation, not homocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 2001;60:1844-1850.
15. Zoccali C: Cardiovascular risk in uraemic patients - is it fully explained by classical risk factors? Nephrol Dial Transplant 2000;15: 454-457.
16. Canaud B, Cristol JP, Morena M, Leray-Moragues H, Bosc JY, Vaussenat F: Imbalance of oxidants and antioxidants in haemodialysis patients. Blood Purif 1999;17:99-106.
17. Kaysen GA: The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001;12:1549-1557.
18. Van der Weerd NC, Penne EL, van der Dorpel MA, Grooteman MPC, Nube MJ, Bots ML, ter Wee PM, Blankestijn PJ: Hemodiafiltration: a promise for the future? Nephrol Dial Transplant 2008;23:438-443.
19. Walker RJ, Sutherland WH, De Jong SA: Effect of changing from a cellulose acetate to a polysulphone dialysis membrane on protein oxidation and inflammation markers. Clin Nephrol 2004;61:198-206.
20. Wanner C, Bahner U, Mattern R, Lang D, Passlick-Deetjen J: Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients. Nephrol Dial Transplant 2004;19:2570-2575.
21. Pupim LB, Himmelfarb J, McMonagle E, Shur Y, Ikizler TA: Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress. Kidney Int 2004;65:2371-2379.
22. Ward RA, Ouseph R, McLeish KR: Effects of high-flux hemodialysis on oxidant stress. Kidney Int 2003;63:353-359.
23. Cheung AK, Levin NW, Greene T, Agodoa L, Bailey J, Beck G, Clark W, Levey AS, Leypoldt JK, Ornt DB, Rocco MV, Schulman G, Schwab S, Teehan B, Eknoyan G: Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 2003;14:3251-3263.
24. Honda H, Qureshi AR, Heimbürger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B: Serum albumin, C-reactive protein, interleukin-6 and fetuin A as predictors of malnutrition, cardiovascular disease and mortality in ESRD patients. Am J Kidney Dis 2006;47:139-148.
25. Senol E, Ersoy A, Erdinc S, Sarandol E, Yurtkuran M: Oxidative stress and ferritin levels in haemodialysis patients. Nephrol Dial Transplant 2008;23:665-672.
26. Wanner C, Zimmermann J, Schwedler S, Metzger T: Inflammation and cardiovascular risk in dialysis patients. Kidney Int 2002; 61:99-102.
27. Korevaar JC, Van Manen JG, Dekker FW, de Waart DR, Boeschoten EW, Kriediet R; for the NECOSAD Study Group: Effect of an increase in C-reactive protein level during a hemodialysis session on mortality. J Am Soc Nephrol 2004;15:2916-2922.
28. Lacson E, Levin N: C-reactive protein and end-stage renal disease. Semin Dial 2004;17: 438-448.
29. Ayus JC, Mizani MR, Achinger SG, Thadhani R, Go AS, Lee S: Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol 2005;16:2778-2788.
30. Panichi V, Rizza GM, Taccola D, Paolletti S, Mantuano E, Migliori M, Frangioni S, Filippi C, Carpi A: C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes. Biomed Pharmacother 2006;60:14-17.
31. Jacobs P, Glorieux G, Vanholder R: Interleukin/ cytokine profiles in hemodialysis and in continuous peritoneal dialysis. Nephrol Dial Transplant 2004;19(suppl 5):41-45.
32. Lin YF, Chang DM, Shaio MF, Lu KC, Chyr SH, Li BL, Sheih S: Cytokine production during hemodialysis: effects of dialytic membrane and complement activation. Am J Nephrol 1996;16:293-299.
33. Friedrich B, Alexander D, Janessa A, Häring HU, Lang F, Risler T: Acute effects of hemodialysis on cytokine transcription profiles: evidence for C-reactive protein dependency of mediator induction. Kidney Int 2006;70: 2124-2130.
34. Amore A, Coppo R: Immunological basis of inflammation in dialysis. Nephrol Dial Transplant 2002;17(suppl 8):16-24.
35. Menon V, Greene T, Wang X, Pereira A, Marcovina SM, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ: C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005;68:766-772.
36. Tetta C, Biasoli S, Schiavon R, Inguaggiato P, David S, Panichi V, Wratten ML: An overview of haemodialysis and oxidant stress. Blood Purif 1999;17:118-126.
37. Gerardi G, Usberti M, Martini G, Albertini A, Sugherini L, Pompella A, Di LD: Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med 2002;40:104-110.
38. Tomo T, Matsuyama K, Nasu M: Effect of hemodiafiltration against radical stress in the course of blood purification. Contrib Nephrol. Basel, Karger, 2007, vol 158, pp 94-102.
39. Gerdemann A, Wagner Z, Solf A, Bahner U, Heidland A, Vienken J, Schinzel R:Plasma levels of advanced glycation end products during hemodialysis, hemodiafiltration and hemofiltration: potential importance of dialysate quality. Nephrol Dial Transplant 2002;17:1045-1049.
40. 2-microglobulin by online hemodiafiltration. Am J Nephrol 1998;18:105-108.
41. Jaffrin MY: Convective mass transfer in hemodialysis. Artif Organs 1995;19:1162-1171.
42. De Francisco ALM, Ghezzi PM, Brendolan A, Fiorini F, La Greca G, Ronco C, Arios M, Gervasio R, Tetta C: Hemodiafiltration with online regeneration of the ultrafiltrate. Kidney Int 2000;58:66-71.
43. Panichi V, Manca-Rizza G, Paoletti S, Taccola D, Consani C, Filippi C, Mantuano E, Sidoti A, Grazi G, Antonelli A, Angelini D, Petrone I, Mura C, Tolaini P, Saloi F, Ghezzi PM, Barsotti G, Palla R: Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs. online haemodiafiltration: a cross-over randomized multicentre trial. Nephrol Dial Transplant 2006;21:756-762.
44. Calo AC, Naso A, Carraro G, Wratten ML, Pagnin E, Bertipaglia L, Rebeschini M, Davis PA, Piccoli A, Cascone C: Effect of hemodiafiltration with on-line regeneration of ultrafiltrate on oxidative stress in dialysis patients. Nephrol Dial Transplant 2007;22:1413-1419.